SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Staar Surgical STAA
STAA 25.27+0.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Enderle who wrote (17)3/30/1999 1:05:00 PM
From: Alan A. Hicks   of 50
 
STAAR's ICL seems to be generating some interest among eye surgeons judging from the number of papers being presented by eye doctors attending the American Society of Cataract and Refractive Surgery (ASCRS) Convention April 9 through April 14 in Seattle, Washington. On the ASCRS website I counted 13 papers and two films being presented relating to the ICL. In addition, the ASCRS Convention will have a course to train eye surgeons how to implant the ICL.

Also, seven papers are being presented on different STAAR IOLs including two papers on STAAR's new Toric IOL lens. A paper and a film also are being presented on the AquaFlow Glaucoma Wick.

It seems to be a significant convention. Over 200 companies are participating with product exhibits for various aspects of eye surgery and opthalmic practice. These include all the major companies in the field such as Bausch & Lomb, Allergan, Alcon, Pharmacia, Summit Technology, and VISX.

There will even be a special event for the 50th anniversary of the IOL. Millions of IOLs for cataract patients have been implanted worldwide by thousands of eye surgeons. These eye surgeons apparently are eager to extend their IOL cataract practice with new technologies such as the ICL and the AquaFlow Wick.

Financial analysts are also are expected attend this convention. With STAAR's shares selling just above a four year low hopefully some of this interest from eye surgeons will get noticed by the financial analysts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News